RAB0537
人FABP2 /脂肪酸结合蛋白，肠道ELISA试剂盒
for serum, plasma, cell culture supernatants and urine
别名:
FABP2 ELISA 试剂盒, 肠道 FABP2 检测
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
NACRES:
NA.32
UNSPSC Code:
41116158
Gene information:
human ... FABP2(2169)
Input:
sample type plasma
sample type serum
sample type urine
sample type cell culture supernatant(s)
sample type serum
sample type urine
sample type cell culture supernatant(s)
Species reactivity:
human
Storage temp.:
−20°C
Shipped in:
wet ice
species reactivity
human
packaging
kit of 96 wells (12 strips x 8 wells)
technique(s)
ELISA: suitable
input
sample type plasma
sample type serum
sample type urine
sample type cell culture supernatant(s)
assay range
inter-assay cv: <10%
intra-assay cv: <12%
sensitivity: 25 pg/mL
detection method
colorimetric
shipped in
wet ice
storage temp.
−20°C
Gene Information
human ... FABP2(2169)
General description
该试剂盒提供的抗体对可检测血清、血浆、细胞培养上清液和尿液中的人肠型脂肪酸结合蛋白。
脂肪酸结合蛋白(FABP2)是由定位于人类染色体4q28–q31的基因编码的细胞内蛋白质。主要分布于肠上皮细胞。FABP2基因编码肠型FABP蛋白(I-FABP)。
脂肪酸结合蛋白(FABP2)是由定位于人类染色体4q28–q31的基因编码的细胞内蛋白质。主要分布于肠上皮细胞。FABP2基因编码肠型FABP蛋白(I-FABP)。
Application
仅供研究使用。不可用于诊断操作。
请参考附带的一般ELISA试剂盒操作程序（夹心、竞争性 & 间接ELISA）
请参考附带的一般ELISA试剂盒操作程序（夹心、竞争性 & 间接ELISA）
Biochem/physiol Actions
脂肪酸结合蛋白(FABP2)在膳食长链脂肪酸的吸收和细胞内转运中起着重要作用。也支持脂肪酸代谢。FABP2可能是糖尿病和胰岛素抵抗的候选基因。还参与脂质代谢和脂肪生成。
Other Notes
本产品提供样本检验报告。
请在批号对应的文本框中输入样品 一词。
请在批号对应的文本框中输入样品 一词。
signalword
Warning
hcodes
pcodes
Hazard Classifications
Met. Corr. 1
flash_point_f
Not applicable
flash_point_c
Not applicable
存储类别
10 - Combustible liquids
法规信息
新产品
此项目有
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.
Furuhashi M and Gokhan S H
Nature Reviews. Drug Discovery, 7(6), 489-489 (2008)
Brynjulf Mortensen et al.
Gastroenterology, 157(3), 637-646 (2019-05-17)
Enteropathy and small-intestinal ulcers are common adverse effects of nonsteroidal anti-inflammatory drugs such as acetylsalicylic acid (ASA). Safe, cytoprotective strategies are needed to reduce this risk. Specific bifidobacteria might have cytoprotective activities, but little is known about these effects in
Nicole U Stoffel et al.
The Lancet. Haematology, 4(11), e524-e533 (2017-10-17)
Current guidelines to treat iron deficiency recommend daily provision of ferrous iron divided through the day to increase absorption. However, daily dosing and split dosing might increase serum hepcidin and decrease iron absorption from subsequent doses. Our study aim was
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| RAB0537-1KT | 04061834963370 |